Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke

References

• Slot KB, Berge E, Dorman P, et al. Oxfordshire community stroke project, the international stroke trial (UK): Lothian stroke register: impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ. 2008;336:376–379.
   PubMed Web of Science ®Google Scholar
• Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke. 1995;26:1293–1301.
   PubMed Web of Science ®Google Scholar
• Inzitari D. Leukoaraiosis: an independent risk factor for stroke? Stroke. 2003;34:2067–2071.
   PubMed Web of Science ®Google Scholar
• Pantoni L, Simoni M, Pracucci G, et al. Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced? Stroke. 2002;33:2827–2833.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838.
   PubMed Web of Science ®Google Scholar
• Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652–659.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Pantoni L. Sporadic small vessel disease: pathogenic aspects. In: Pantoni L, Gorelick PB, editors. Cerebral small vessel disease. Cambridge (UK): Cambridge University Press; 2014. p. 52–63.
   Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.
   PubMed Web of Science ®Google Scholar
• Piccini P, Pavese N, Canapicchi R, et al. White matter hyperintensities in Parkinson’s disease. Clinical correlations. Arch Neurol. 1995;52:191–194.
   PubMedGoogle Scholar
• O’Brien J, Ames D, Chiu E, et al. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ. 1998;317:982–984.
   PubMed Web of Science ®Google Scholar
• Moore PB, Shepherd DJ, Eccleston D, et al. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry. 2001;178:172–176.
   PubMed Web of Science ®Google Scholar
• Pantoni L. Leukoaraiosis: from an ancient term to an actual marker of poor prognosis. Stroke. 2008;39:1401–1403.
   PubMed Web of Science ®Google Scholar
• Oksala NK, Oksala A, Pohjasvaara T, et al. Age related white matter changes predict stroke death in long term follow-up. J Neurol Neurosurg Psychiatry. 2009;80:762–766.
   PubMed Web of Science ®Google Scholar
• Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009;339:b2477.
   PubMed Web of Science ®Google Scholar
• Sibolt G, Curtze S, Melkas S, et al. White matter lesions are associated with hospital admissions because of hip-fractures and trauma after ischemic stroke. Stroke. 2014;45:2948–2951.
   PubMed Web of Science ®Google Scholar
• Dávalos A, Blanco M, Pedraza S, et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004;62:2187–2192.
   PubMed Web of Science ®Google Scholar
• Gasparotti R, Grassi M, Mardighian D, et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome. AJNR Am J Neuroradiol. 2009;30:722–727.
   PubMed Web of Science ®Google Scholar
• Parsons MW, Christensen S, McElduff P, et al. Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010;30:1214–1225.
   PubMed Web of Science ®Google Scholar
• Henninger N, Lin E, Haussen DC, et al. Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke. 2013;44:61–67.
   PubMed Web of Science ®Google Scholar
• Henninger N, Khan MA, Zhang J, et al. Leukoaraiosis predicts cortical infarct volume after distal middle cerebral artery occlusion. Stroke. 2014;45:689–695.
   PubMed Web of Science ®Google Scholar
• Ay H, Arsava EM, Rosand J, et al. Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke. 2008;39:1409–1413.
   PubMed Web of Science ®Google Scholar
• Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry. 2008;79:1093–1099.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Kellert L, Lees KR, et al. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study. JAMA Neurol. 2013;70:837–844.
   PubMed Web of Science ®Google Scholar
• Pantoni L, Fierini F, Poggesi A. Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis. 2014;37:5–13.
   PubMed Web of Science ®Google Scholar
• Shi ZS, Loh Y, Liebeskind DS, et al. Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke. 2012;43:1806–1811.
   PubMed Web of Science ®Google Scholar
• Jung S, Mono ML, Findling O, et al. White matter lesions and intra-arterial thrombolysis. J Neurol. 2012;259:1331–1336.
   PubMed Web of Science ®Google Scholar
• Palumbo V, Boulanger JM, Hill MD, et al. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology. 2007;68:1020–1024.
   PubMed Web of Science ®Google Scholar
• Demchuk AM, Khan F, Hill MD, et al. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rtPA Stroke Study. Cerebrovasc Dis. 2008;26:120–125.
   PubMed Web of Science ®Google Scholar
• Ariës MJH, Uyttenboogaart M, Vroomen PC, et al. tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol. 2010;17:866–870.
   PubMed Web of Science ®Google Scholar
• Henninger N, Lin E, Baker SP, et al. Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion. Cerebrovasc Dis. 2012;33:525–531.
   PubMed Web of Science ®Google Scholar
• Curtze S, Melkas S, Sibolt G, et al. Cerebral computed tomography-graded white matter lesions are associated with worse outcome after thrombolysis in patients with stroke. Stroke. 2015;46:1554–1560.
   PubMed Web of Science ®Google Scholar
• Fiorelli M, Di Piero V, Vicenzini E, et al. Leukoaraiosis was not associated with an increase of parenchymal hemorrhage in the combined ecass 1-ecass 2 cohort (abstract). Stroke. 2002;33:382.
   Web of Science ®Google Scholar
• Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke. 2006;37:2463–2466.
   PubMed Web of Science ®Google Scholar
• Fiehler J, Siemonsen S, Thomalla G, et al. Combination of T2*W and FLAIR abnormalities for the prediction of parenchymal hematoma following thrombolytic therapy in 100 stroke patients. J Neuroimaging. 2009;19:311–316.
   PubMed Web of Science ®Google Scholar
• Choi JH, Bae HJ, Cha JK. Leukoaraiosis on magnetic resonance imaging is related to long-term poor functional outcome after thrombolysis in acute ischemic stroke. J Korean Neurosurg Soc. 2011;50:75–80.
   PubMed Web of Science ®Google Scholar
• Costello CA, Campbell BC, Perez de la Ossa N, et al. Age over 80 years is not associated with increased hemorrhagic transformation after stroke thrombolysis. J Clin Neurosci. 2012;19:360–363.
   PubMed Web of Science ®Google Scholar
• IST-3 collaboration group. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third international stroke trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol. 2015;14:485–496.
   PubMed Web of Science ®Google Scholar
• Willer L, Havsteen I, Ovesen C, et al. Computed tomography-verified leukoaraiosis is a risk factor for post-thrombolytic hemorrhage. J Stroke Cerebrovasc Dis. 2015;24:1126–1130.
   PubMed Web of Science ®Google Scholar
• Lin Q, Li Z, Wei R, et al. Increased risk of post-thrombolysis intracranial hemorrhage in acute ischemic stroke patients with leukoaraiosis: a meta-analysis. PLoS One. 2016;11:e0153486.
   PubMed Web of Science ®Google Scholar
• Charidimou A, Pasi M, Fiorelli M, et al. Leukoaraiosis, cerebral Hemorrhage, and outcome after intravenous thrombolysis for acute ischemic stroke: a meta-analysis (v1). Stroke. 2016;47:2364–2372.
   PubMed Web of Science ®Google Scholar
• Kongbunkiat K, Wilson D, Kasemsap N, et al. Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis. Neurology. 2017;88:638–645.
   PubMed Web of Science ®Google Scholar
• Zhang J, Puri AS, Khan MA, et al. Leukoaraiosis predicts a poor 90-day outcome after endovascular stroke therapy. AJNR Am J Neuroradiol. 2014;35:2070–2075.
   PubMed Web of Science ®Google Scholar
• Hussein HM, Georgiadis AL, Vazquez G, et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol. 2010;31:454–458.
   PubMed Web of Science ®Google Scholar
• Gilberti N, Gamba M, Premi E, et al. Leukoaraiosis is a predictor of futile recanalization in acute ischemic stroke. J Neurol. 2017;264:448–452.
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam scan study. Stroke. 2003;34:1126–1129.
   PubMed Web of Science ®Google Scholar
• Miyao S, Takano A, Teramoto J, et al. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke. 1992;23:1434–1438.
   PubMed Web of Science ®Google Scholar
• Liou LM, Chen CF, Guo YC, et al. Cerebral white matter hyperintensities predict functional stroke outcome. Cerebrovasc Dis. 2010;29:22–27.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Stewart R, Park MS, et al. White matter hyperintensities and functional outcomes at 2 weeks and 1 year after stroke. Cerebrovasc Dis. 2013;35:138–145.
   PubMed Web of Science ®Google Scholar
• Ryu WS, Woo SH, Schellingerhout D, et al. Stroke outcomes are worse with larger leukoaraiosis volumes. Brain. 2017;140:158–170.
   PubMed Web of Science ®Google Scholar
• Jørgensen HS, Nakayama H, Raaschou HO, et al. Leukoaraiosis in stroke patients. The Copenhagen Stroke Study. Stroke. 1995;26:588–592.
   PubMed Web of Science ®Google Scholar
• Wiszniewska M, Devuyst G, Bogousslavsky J, et al. What is the significance of leukoaraiosis in patients with acute ischemic stroke? Arch Neurol. 2000;57:967–973.
   PubMedGoogle Scholar
• McAlpine H, Churilov L, Mitchell P, et al. Leukoaraiosis and early neurological recovery after intravenous thrombolysis. J Stroke Cerebrovasc Dis. 2014;23:2431–2436.
   PubMed Web of Science ®Google Scholar
• Onteddu SR, Goddeau RP Jr, Minaeian A, et al. Clinical impact of leukoaraiosis burden and chronological age on neurological deficit recovery and 90-day outcome after minor ischemic stroke. J Neurol Sci. 2015;359:418–423.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim BJ, Ryu WS, et al. White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study. Neurology. 2010;74:1502–1510.
   PubMed Web of Science ®Google Scholar
• Tveiten A, Ljøstad U, Mygland Å, et al. Leukoaraiosis is associated with short- and long-term mortality in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2013;22:919–925.
   PubMed Web of Science ®Google Scholar
• Caprio FZ, Maas MB, Rosenberg NF, et al. Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage. Stroke. 2013;44:642–646.
   PubMed Web of Science ®Google Scholar
• Won YS, Chung PW, Kim YB, et al. Leukoaraiosis predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage. Eur Neurol. 2010;64:253–257.
   PubMed Web of Science ®Google Scholar
• Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641–1646.
   PubMed Web of Science ®Google Scholar
• Ogata J, Yamanishi H, Hishibashi-Ueda H. Pathology of cerebral small vessel disease. In: Pantoni L, Gorelick PB, editors. Cerebral Small Vessel Disease. Cambridge (UK): Cambridge University Press; 2014. p. 4–15.
   Google Scholar
• del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879–894.
   PubMed Web of Science ®Google Scholar
• Marstrand JR, Garde E, Rostrup E, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke. 2002;33:972–976.
   PubMed Web of Science ®Google Scholar
• Uh J, Yezhuvath U, Cheng Y, et al. In vivo vascular hallmarks of diffuse leukoaraiosis. J Magn Reson Imaging. 2010;32:184–190.
   PubMed Web of Science ®Google Scholar
• Dumas A, Dierksen GA, Gurol ME, et al. Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol. 2012;72:76–81.
   PubMed Web of Science ®Google Scholar
• Hassan A, Hunt BJ, O’Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126:424–432.
   PubMed Web of Science ®Google Scholar
• Markus HS, Hunt B, Palmer K, et al. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke. 2005;36:1410–1414.
   PubMed Web of Science ®Google Scholar
• Fornage M, Chiang YA, O’Meara ES, et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study. Stroke. 2008;39:1952–1959.
   PubMed Web of Science ®Google Scholar
• Thompson CS, Hakim AM. Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke. 2009;40:e322–e330.
   PubMed Web of Science ®Google Scholar
• Knottnerus IL, Govers-Riemslag JW, Hamulyak K, et al. Endothelial activation in lacunar stroke subtypes. Stroke. 2010;41:1617–1622.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM. Neuroimaging in acute ischaemic stroke: insights into unanswered questions of pathophysiology. J Intern Med. 2010;267:172–190.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483–497.
   PubMed Web of Science ®Google Scholar
• Hainsworth AH, Oommen AT, Bridges LR. Endothelial cells and human cerebral small vessel disease. Brain Pathol. 2015;25:44–50.
   PubMed Web of Science ®Google Scholar
• Braun H, Bueche CZ, Garz C, et al. Stases are associated with blood-brain barrier damage and a restricted activation of coagulation in SHRSP. J Neurol Sci. 2012;322:71–76.
   PubMed Web of Science ®Google Scholar
• Nakaji K, Ihara M, Takahashi C, et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 2006;37:2816–2823.
   PubMed Web of Science ®Google Scholar
• Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger’s disease. Stroke. 1995;26:52–56.
   PubMed Web of Science ®Google Scholar
• Tomimoto H, Akiguchi I, Ohtani R, et al. The coagulation fibrinolysis system in patients with leukoaraiosis and Binswanger disease. Arch Neurol. 2001;58:1620–1625.
   PubMedGoogle Scholar
• Poggesi A, Pasi M, Pescini F, et al. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J Cereb Blood Flow Metab. 2016;36:72–94.
   PubMed Web of Science ®Google Scholar
• Ames A 3rd, Wright RL, Kowada M, et al. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol. 1968;52:437–453.
   PubMed Web of Science ®Google Scholar
• Dalkara T, Arsava EM. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? J Cereb Blood Flow Metab. 2012;32:2091–2099.
   PubMed Web of Science ®Google Scholar
• Moody DM, Thore CR, Anstrom JA, et al. Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology. 2004;233:883–890.
   PubMed Web of Science ®Google Scholar
• Brown WR, Moody DM, Thore CR, et al. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci. 2007;257:62–66.
   PubMed Web of Science ®Google Scholar
• Sanossian N, Ovbiagele B, Saver JL, et al. Leukoaraiosis and collaterals in acute ischemic stroke. J Neuroimaging. 2011;21:232–235.
   PubMed Web of Science ®Google Scholar
• Giurgiutiu D-V, Yoo AJ, Fitzpatrick K, et al. Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke. J NeuroIntervent Surg. 2015;7:326–330.
   PubMed Web of Science ®Google Scholar
• Winship IR. Cerebral collaterals and collateral therapeutics for acute ischemic stroke. Microcirculation. 2015;22:228–236.
   PubMed Web of Science ®Google Scholar
• Shin HK, Nishimura M, Jones PB, et al. Mild induced hypertension improves blood flow and oxygen metabolism in transient focal cerebral ischemia. Stroke. 2008;39:1548–1555.
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, von Kummer R, Hamann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65:1–9.
   PubMed Web of Science ®Google Scholar
• Kahles T, Foerch C, Sitzer M, et al. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent. Vasc Pharmacol. 2005;43:254–259.
   PubMed Web of Science ®Google Scholar
• Llombart V, Dominguez C, Bustamante A, et al. Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis. Stroke. 2014;45:432–437.
   PubMed Web of Science ®Google Scholar
• De Silva TM, Miller AA. Cerebral small vessel disease: targeting oxidative stress as a novel therapeutic strategy? Front Pharmacol. 2016;7:61.
   PubMed Web of Science ®Google Scholar
• Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399–415.
   PubMed Web of Science ®Google Scholar
• Ning M, Furie KL, Koroshetz WJ, et al. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology. 2006;66:1550–1555.
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A, Tepper D, et al. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol. 2013;4:32.
   PubMed Web of Science ®Google Scholar
• Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol:2009;8:205–216.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu W, Yun W, et al. Correlation of matrix metalloproteinase-2 single nucleotide polymorphisms with the risk of small vessel disease (SVD). J Neurol Sci. 2015;356:61–64.
   PubMed Web of Science ®Google Scholar
• Ishihara M, Kumita S, Hayashi H, et al. Loss of interhemispheric connectivity in patients with lacunar infarction reflected by diffusion-weighted MR imaging and single-photon emission CT. AJNR Am J Neuroradiol. 1999;20:991–998.
   PubMed Web of Science ®Google Scholar
• Nordahl CW, Ranganath C, Yonelinas AP, et al. White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci. 2006;18:418–429.
   PubMed Web of Science ®Google Scholar
• Fisher CM. Binswanger’s encephalopathy: a review. J Neurol. 1989;236:65–79.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Müller ML, Kuwabara H, et al. Age-associated leukoaraiosis and cortical cholinergic deafferentation. Neurology. 2009;72:1411–1416.
   PubMed Web of Science ®Google Scholar
• Lawrence AJ, Chung AW, Morris RG, et al. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 2014;83:304–311.
   PubMed Web of Science ®Google Scholar
• Tuladhar AM, van Dijk E, Zwiers MP, et al. Structural network connectivity and cognition in cerebral small vessel disease. Hum Brain Mapp. 2016;37:300–310.
   PubMed Web of Science ®Google Scholar
• Peña ID, Borlongan C, Shen G, et al. Strategies to extend thrombolytic time window for ischemic stroke treatment: an unmet clinical need. J Stroke. 2017;19:50–60.
   PubMed Web of Science ®Google Scholar
• Hasan N, McColgan P, Bentley P, et al. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol. 2012;74:230–240.
   PubMed Web of Science ®Google Scholar
• Rosenberg GA. Extracellular matrix inflammation in vascular cognitive impairment and dementia. Clin Sci (Lond). 2017;131:425–437.
   PubMed Web of Science ®Google Scholar
• Gori AM, Giusti B, Piccardi B, et al. Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis. J Cereb Blood Flow Metab. 2017. DOI:10.1177/0271678X17695572
   PubMed Web of Science ®Google Scholar